Cargando…
Cistracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages: A Stability Study Involving Four Degradation Products
Background: Stability study of a 10 mg/mL injectable cisatracurium solution stored refrigerated in amber glass ampoules for 18 months (M18). Methods: 4000 ampoules were aseptically compounded using European Pharmacopoeia (EP)-grade cisatracurium besylate, sterile water for injection, and benzenesulf...
Autores principales: | Roche, Marine, Danel, Cécile, Simon, Nicolas, Kouach, Mostafa, Bouchfaa, Myriam, Berneron, Christophe, Odou, Pascal, Lannoy, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221331/ https://www.ncbi.nlm.nih.gov/pubmed/37242646 http://dx.doi.org/10.3390/pharmaceutics15051404 |
Ejemplares similares
-
Behavior of Regular Insulin in a Parenteral Nutrition Admixture: Validation of an LC/MS-MS Assay and the In Vitro Evaluation of Insulin Glycation
por: Henry, Heloise, et al.
Publicado: (2022) -
Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013) -
Predicting drug shortages using pharmacy data and machine learning
por: Pall, Raman, et al.
Publicado: (2023) -
Formulation and Evaluation of S-(-)-Amlodipine Besylate and Nebivolol Hydrochloride Tablets
por: Shaikh, S.A, et al.
Publicado: (2010) -
Chronic unilateral chemosis following the use of amlodipine besylate
por: Kim, Kyeong Hwan, et al.
Publicado: (2014)